Collaboration - September 15, 2022
Lundbeck joins Real World Data consortium
The company has become a partner of EHDEN, a private-public partnership that is building a large-scale, federated network of data sources standardized to a common data model. Lundbeck now joins the 11 public partners, and 12 industry partners, adding our expertise, resources, and support in creating an ecosystem for working with real world data across […]
Collaboration - September 13, 2022
Our latest issue of NLS Magazine is out!
In this 108-page issue we have chosen to take a closer look at five Nordic innovation districts, at different development stages and with different challenges and life science offerings, but with the same goal of facilitating knowledge transfer and spurring innovation and life science growth in our region and beyond. In addition, we present our […]
Collaboration - September 13, 2022
Novo Nordisk and Microsoft enter collaboration
The two companies have entered a new strategic collaboration to combine Microsoft’s computational services, cloud and artificial intelligence with Novo Nordisk’s drug discovery, development and data science capabilities. Through the partnership, Microsoft is providing AI technology, foundational science models and expertise and is working alongside Novo Nordisk’s data scientists and domain experts from early research […]
Collaboration - August 31, 2022
Kaiku Health expands partnership with Novartis
Last year Kaiku Health announced its collaboration with Novartis in developing digital patient monitoring and management for melanoma patients. Following the success of the collaboration, Kaiku Health and Novartis are now expanding it into a partnership, they state. “The cooperation so far has shown that together we can enhance the monitoring and symptom management of […]
Collaboration - August 30, 2022
Zerion Pharma collaborates with Insud Pharma
Zerion Pharma and the Spanish pharmaceutical group Insud Pharma will develop and commercialize drug products applying ZERION’s Dispersome technology. Zerion will develop Dispersome formulations of marketed drug products while Insud will be responsible for the finished product dosage form, the clinical development as well as global marketing and sales of the final products. A worldwide […]
Collaboration - August 17, 2022
Genmab and BioNTech expand global strategic collaboration
The two companies have announced an expansion of their collaboration to develop and commercialize novel immunotherapies for the treatment of cancer patients. Under the expansion, Genmab and BioNTech will jointly work to research, develop, and commercialize novel monospecific antibody candidates for various cancer indications. Since 2015, the companies have been working on the joint development […]
